Trial
NCT05074420
A Study of Baricitinib (LY3009104) in Children With COVID-19
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Covid19
Intervention
Baricitinib
Why stopped
Study terminated due to an inability to enroll participants.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-17